Skip to main content

Sagent gets OK for antibacterial drug

7/5/2011

SCHAUMBURG, Ill. — Sagent has received approval from the Food and Drug Administration for its antibacterial drug.


The drug maker said that the FDA approved polymyxin B for injection USP. Sagent said that polymyxin B sulfate is used to treat infections of the urinary tract, meninges and bloodstream caused by susceptible strains of Pseudomonas aeruginosa.


The drug was developed in partnership with Strides Arcolab. Under the collaboration, Strides develops and supplies injectable products that Sagent will market in the United States.

X
This ad will auto-close in 10 seconds